- Home
- FURY vs ORMP Comparison
FURY vs ORMP Comparison
Compare FURY & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FURY
- ORMP
- Stock Information
- Founded
- FURY 2008
- ORMP 2002
- Country
- FURY Canada
- ORMP United States
- Employees
- FURY N/A
- ORMP N/A
- Industry
- FURY Precious Metals
- ORMP Biotechnology: Pharmaceutical Preparations
- Sector
- FURY Basic Materials
- ORMP Health Care
- Exchange
- FURY Nasdaq
- ORMP Nasdaq
- Market Cap
- FURY 84.1M
- ORMP 90.2M
- IPO Year
- FURY N/A
- ORMP N/A
- Fundamental
- Price
- FURY $0.70
- ORMP $2.29
- Analyst Decision
- FURY Strong Buy
- ORMP Hold
- Analyst Count
- FURY 2
- ORMP 1
- Target Price
- FURY $1.40
- ORMP N/A
- AVG Volume (30 Days)
- FURY 673.2K
- ORMP 94.3K
- Earning Date
- FURY 11-11-2025
- ORMP 11-06-2025
- Dividend Yield
- FURY N/A
- ORMP N/A
- EPS Growth
- FURY N/A
- ORMP N/A
- EPS
- FURY N/A
- ORMP N/A
- Revenue
- FURY N/A
- ORMP $2,000,000.00
- Revenue This Year
- FURY N/A
- ORMP N/A
- Revenue Next Year
- FURY N/A
- ORMP N/A
- P/E Ratio
- FURY N/A
- ORMP N/A
- Revenue Growth
- FURY N/A
- ORMP N/A
- 52 Week Low
- FURY $0.35
- ORMP $1.82
- 52 Week High
- FURY $0.73
- ORMP $3.09
- Technical
- Relative Strength Index (RSI)
- FURY 67.57
- ORMP 56.24
- Support Level
- FURY $0.64
- ORMP $2.17
- Resistance Level
- FURY $0.73
- ORMP $2.45
- Average True Range (ATR)
- FURY 0.05
- ORMP 0.07
- MACD
- FURY 0.01
- ORMP 0.01
- Stochastic Oscillator
- FURY 86.26
- ORMP 52.94
About FURY Fury Gold Mines Limited
Fury Gold Mines Ltd is a Canadian-focused exploration and development company strategically positioned in three prolific mining regions: James Bay, Quebec; the Golden Triangle, British Columbia; and the Kitikmeot Region Nunavut. Its projects include Eau Claire, Homestake Ridge, Committee Bay, Eleonore South JV, and Gibson MacQuoid.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.